Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians
2 other identifiers
interventional
8
1 country
1
Brief Summary
Hypotheses and Specific Aims: The continued emergence of antibiotic-resistance in the outpatient setting underlines the need to responsibly manage antimicrobial prescribing. It is in this context that we seek to test an effective strategy for reducing the inappropriate use of antibiotics in primary care office practices. Our overall objective is to identify an effective and efficient strategy for decreasing the contribution of primary care clinicians to the emergence of antimicrobial-resistant bacteria in the community and to disseminate widely those strategies found to be effective and sustainable. We hypothesize that implementation of a clinician decision support system, with an active education component, will reduce the inappropriate use of antibiotics in primary care office practices. Our hypothesis is based on the premise that most inappropriate prescribing is the result of multiple factors that include difficulty in distinguishing a benign, self-limited viral infection from a more serious bacterial infection; overdiagnosis of a bacterial infection in cases where there is clinical uncertainty as to the true nature of the illness; and constraints on the time available for clinicians to explain to patients the nature of the illness and the reasons an antibiotic is not indicated. The focus of this proposal will be to compare the impact of clinical decision support and active education to no intervention for enhancing the appropriate use of antimicrobials for common outpatient infections. In this randomized control trial, primary care providers participating in the intervention arm will receive active education coupled with the implementation of a clinical decision support tool, while providers in the control arm will have no intervention. At the end of the study, providers in the control arm will receive a thorough analysis of their antibiotic prescribing patterns and suggested opportunities for improvement, as well as access to the intervention tools once the study has ended. Our interdisciplinary team will integrate novel methods in implementation science with clinical and laboratory expertise in infectious diseases, antimicrobial stewardship, primary care, information technology, performance improvement, health services research, and biostatistics. The Specific Aims are constructed to validate our hypothesis in the primary care setting by demonstrating two results of our intervention strategy:
- 1.Reduced use of antibiotics to treat conditions for which those drugs are known not to be effective
- 2.Decreased prescribing of broad-spectrum antibiotics to treat common bacterial infections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 3, 2009
CompletedFirst Posted
Study publicly available on registry
April 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedOctober 6, 2015
October 1, 2015
3 years
November 3, 2009
October 5, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Change in antibiotics prescribing behavior
December 2009 through August 2011
Secondary Outcomes (1)
The number and type of changes made to workflow processes when setting up or changing systems to change prescribing methods
December 2009 through August 2011
Study Arms (2)
Intervention: Education, Decision Support Tools
EXPERIMENTALClinic sites randomized to the intervention group will participate in an educational intervention comprised of lectures on antimicrobial resistance and implement decision support tools to guide primary care providers in appropriate antibiotic prescribing for common infectious conditions.
No education, no implemented decision support tools
NO INTERVENTIONClinics randomized to the control will not participate in the education intervention and implementation of decision support tools.
Interventions
Clinic sites randomized to the intervention group will participate in an educational intervention comprised of lectures on antimicrobial resistance and implement decision support tools to guide primary care providers in appropriate antibiotic prescribing for common infectious conditions.
Eligibility Criteria
You may qualify if:
- Clinic practices within Denver Health's Webb Center for Primary Care,
- Clinic practices within the University of Colorado - Anschutz Campus: General Internal Medicine Clinic,
- Clinic practices within the High Plains Network, and
- Clinical practices within the Wilmington Health Associates System
- The antibiotic prescribing patterns of primary care clinicians in these practices will be monitored over a 2 year period. Practices must be willing to assist in tracking:
- Patient records (pediatric and adult) for conditions related to the International Classification of Diseases (ICD-9) codes associated with common infectious conditions (Upper Respiratory Infection, Acute Bronchitis, Pharyngitis, Acute Sinusitis, Otitis Media, Acute Cystitis, Cellulitis or soft tissue abscess, and Community-acquired Pneumonia) will be assessed for antibiotic prescribing,
- day events (hospitalizations,
- Note: Emergency Department (ED) visits, or grade 3 or grade 4 abnormalities), will also be included in this study.
You may not qualify if:
- \. Ob/Gyn related clinic visits will not be included in this study as these visits are not typically associated with high volumes of antibiotic prescribing for the infectious conditions of interest.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Denver Health and Hospitals Authority
Denver, Colorado, 80204, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David R West, PhD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2009
First Posted
April 8, 2010
Study Start
August 1, 2009
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
October 6, 2015
Record last verified: 2015-10